Back
Consortium Clinical Research Gets Service Tax Exemption as CESTAT Rejects Need for Separate DCGI Approval
The Chennai bench of the has held that a Clinical Research Organisation (CRO) need not hold a separate approval from the to claim service tax exemption on testing of new drugs. The ruling came in an appeal by against a demand of ₹65.25 lakh, which the tribunal set aside in its entirety.
Background of the Dispute
CCRP, a Coimbatore-based CRO, provides contract research services to pharmaceutical companies, including management of clinical trials on human participants. The Department issued show cause notices alleging that CCRP had rendered
"
"
without paying service tax, and also sought to tax deposits collected from employees as
"
."
The total demand was ₹63.06 lakh on the testing service and ₹2.19 lakh on the training deposit.
The central contention was whether CCRP qualified for the exemption under
and, from
, under
. These notifications exempt testing of newly developed drugs on human participants when undertaken by a CRO
"approved to conduct clinical trials by the Drugs Controller General of India."
The Department argued that since DCGI approvals were issued only to the drug Sponsors (
,
, and
) and not to CCRP, the exemption was unavailable.
No Separate DCGI Approval for CROs – An Impossibility
CCRP argued that under the regulatory framework, DCGI permission is inherently granted to the Sponsor who owns the drug molecule. There is no mechanism for a CRO to obtain such approval independently. To read the exemption as requiring a separate institutional approval would make it impossible for any CRO to ever claim the benefit.
The tribunal agreed, stating:
"To read the exemption as additionally requiring a free-standing institutional approval that the regulator does not, and did not at the relevant time, issue to any CRO would impose a condition no CRO could ever satisfy. Such a reading offends the settled canon that the law does not require the performance of an impossibility, ."
Relying on its earlier decision in , a coordinate Bench of CESTAT had held that a CRO need not hold separate DCGI approval as long as the Sponsor's trial had DCGI approval and the CRO was registered with the . The present bench adopted this reasoning and distinguished the Department's reliance on , noting that in that case the assessee was merely a trial site and not itself acting as a CRO.
Employee Deposit Not Taxable as Training Service
On the second demand, the tribunal found that the ₹2.19 lakh represented deposits collected from employees who were trained and appointed on condition that they serve for one year. If an employee resigned prematurely, the deposit was forfeited or recovered as compensation. The Department had characterised this as a fee for commercial training or coaching.
CESTAT rejected this, holding that the recovery was not
. For the period before
, it fell outside the definition of
"
"
because the training was provided to employees under contracts of service, not to external trainees. For the later period, it did not constitute a
under
. The tribunal cited
, where the had held that notice pay recovered from employees does not amount to a taxable service. The same principle applied here.
Extended Limitation Period Invalid
The Department had invoked the under , alleging . However, the tribunal noted that the Department had examined CCRP's clinical research activities as early as , years before the show cause notices were issued. CCRP had responded fully to those inquiries and had consistently maintained that its testing services were exempt.
"It is difficult to conceive how CCRP can be said to have suppressed from the Department a fact the Department had itself elicited and was already investigating several years in advance of the show cause notices."
The tribunal emphasised that the proviso requires deliberate suppression with intent to evade. An of exemption provisions does not meet that standard. Accordingly, the invocation of the extended period was not sustainable.
Final Decision
Setting aside the entire demand, the tribunal held that the technical testing and analysis services were exempt from service tax, the employee deposit recoveries were not taxable, and the limitation period had not been validly invoked. Consequently, the interest and all penalties imposed under Sections 75, 76, 77, and 78 were also quashed.
The decision reinforces the principle that tax exemption notifications must be construed in light of the regulatory framework they refer to, and that revenue authorities cannot impose conditions that are practically impossible to fulfil. It also clarifies that deposits taken from employees to secure minimum service periods do not constitute consideration for any .
